JP2017512762A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512762A5
JP2017512762A5 JP2016555478A JP2016555478A JP2017512762A5 JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5 JP 2016555478 A JP2016555478 A JP 2016555478A JP 2016555478 A JP2016555478 A JP 2016555478A JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5
Authority
JP
Japan
Prior art keywords
hexafluorophosphate
acid
compound
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016555478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512762A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072267 external-priority patent/WO2015134096A1/en
Publication of JP2017512762A publication Critical patent/JP2017512762A/ja
Publication of JP2017512762A5 publication Critical patent/JP2017512762A5/ja
Pending legal-status Critical Current

Links

JP2016555478A 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法 Pending JP2017512762A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461947286P 2014-03-03 2014-03-03
US61/947,286 2014-03-03
PCT/US2014/072267 WO2015134096A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (2)

Publication Number Publication Date
JP2017512762A JP2017512762A (ja) 2017-05-25
JP2017512762A5 true JP2017512762A5 (https=) 2018-02-08

Family

ID=54055710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016555478A Pending JP2017512762A (ja) 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法

Country Status (7)

Country Link
US (1) US20170081363A1 (https=)
EP (1) EP3114136A4 (https=)
JP (1) JP2017512762A (https=)
CN (1) CN106459169A (https=)
CA (1) CA2942143A1 (https=)
HK (1) HK1231493A1 (https=)
WO (1) WO2015134096A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221213B2 (en) 2013-12-27 2019-03-05 Stealth Biotherapeutics Corp Pharmaceutically relevant aromatic-cationic peptides
EP3265109B1 (en) 2015-03-06 2020-10-21 Stealth BioTherapeutics Corp Processes for preparing pharmaceutically relevant peptides
WO2017043626A1 (ja) * 2015-09-11 2017-03-16 株式会社カネカ 光学活性4-カルバモイル-2,6-ジメチルフェニルアラニン誘導体の製造法
WO2017180535A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
US11034724B2 (en) 2017-04-05 2021-06-15 Stealth Biotherapeutics Corp. Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
US12252554B2 (en) 2018-12-18 2025-03-18 Stealth Biotherapeutics Inc. Analogs that target mitochondrial diseases
TW202346255A (zh) * 2022-01-06 2023-12-01 日商中外製藥股份有限公司 醯胺化合物的製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004501875A (ja) * 2000-06-14 2004-01-22 メダレックス,インコーポレイティド トリペプチドプロドラッグ化合物
PL2604286T3 (pl) * 2003-05-01 2015-03-31 Cornell Res Foundation Inc Sposoby i kompleksy nośnikowe do transportu cząsteczek do komórek
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3375449A1 (en) * 2010-03-15 2018-09-19 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CA2839408A1 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN104244964A (zh) * 2012-02-22 2014-12-24 康肽德生物医药技术有限公司 用于预防或治疗眼科病状的方法和组合物
JP2016506391A (ja) * 2012-12-06 2016-03-03 ステルス ペプチドズ インターナショナル インコーポレイテッド ペプチド治療薬およびその使用方法

Similar Documents

Publication Publication Date Title
JP2017512762A5 (https=)
JP2017502956A5 (https=)
KR101514953B1 (ko) 매크로사이클릭 화합물의 제조방법
ES2552338T3 (es) Compuestos farmacéuticos
KR102371784B1 (ko) 활성화 혈액 응고 제 X 인자 (FXa) 의 저해약의 제조 방법
JP7450572B2 (ja) 薬学的に適切なペプチドを調製するための方法
EP3645529B1 (en) Process for preparing lifitegrast and intermediates thereof
AU2008346833A1 (en) Process for preparing N-substituted hydroxypyrimidinone carboxamides
KR101949551B1 (ko) 벤족사지논을 아민과 반응시켜 테트라졸-치환된 안트라닐산 디아미드 유도체를 제조하는 방법
JP2016535081A5 (https=)
CA2801101A1 (en) Process for preparing a biphenyl-2-ylcarbamic acid
ES2715082T3 (es) Método de producción de un pentapéptido sintético
JP2017512762A (ja) 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法
WO2019026014A1 (en) METHODS FOR PREPARING LIFITEGRAST AND ITS INTERMEDIATES
DK2948441T3 (en) PROCEDURE FOR PREPARING 1- (4- (4- (3,4-DICHLOR-2-FLUORPHENYLAMINO) -7-METHOXYQUINAZOLIN-6-YLOXY) PIPERIDIN-1-YL) PROP-2-EN-1-ON
RU2717830C2 (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
CN107810189B (zh) 用于制备氮芥衍生物的方法
ES2791187T3 (es) Síntesis de dabigatrán
KR20150067175A (ko) 보르테조밉을 제조하기 위한 방법
KR101578979B1 (ko) 라코사마이드의 제조방법
KR20210088651A (ko) 디메톡시벤젠 화합물의 제조 방법
ES2827459T3 (es) Procedimiento para la preparación de apixaban
US10329325B2 (en) Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
US20240002432A1 (en) Method for producing amino acid or peptide, protective group-forming reagent, and compound
EP2773624A1 (en) Novel process for the preparation of acylguanidines and acylthioureas